Search the Newsreel

Option Care Health (OPCH) Beat Expectations, Is The Stock Fully Priced?

Option Care Health (OPCH) recently reported strong Q2 2026 results, exceeding revenue, EBITDA, and EPS expectations, while maintaining guidance and investing in digital tools and clinic expansion. Despite a 15.99% share price rebound over 90 days, the stock is down 26.21% year-to-date and 15.64% …

Option Care Health (OPCH) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, July 29, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Bob OkunskiPresident and Chief Executive Officer - John Charles RademacherExecutive Vice President and Chief Financial Officer - Meenal Anil Sethna Need a …

OPCH vs. PNTG: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care (OPCH) and The Pennant Group, Inc. (PNTG). But which of these two stocks offers value investors a better bang for their buck right now? We'll need …

Maruti Suzuki, ABB India, Chennai Petro, Alkem Labs, Grasim, Sharda Cropchem Dividends: Last Day To Buy Shares To Qualify

Is Option Care Health (OPCH) Stock Undervalued Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends …

Is OPCH’s Buybacks Plus Acquisition Hunt Altering The Investment Case For Option Care Health?

5 Insightful Analyst Questions From Option Care Health’s Q2 Earnings Call

Option Care Health (OPCH) exceeded Wall Street's expectations in Q2 2026 due to strong organic growth in acute therapies, stabilization in chronic inflammatory disease portfolios, and effective cost control. The earnings call highlighted key analyst questions covering revenue mix impact on margins, the speed …

Sharda Cropchem Q1FY27 revenue rises 9%, net profit dips on forex

Sharda Cropchem Limited (NSE:SHARDACROP) Passed Our Checks, And It's About To Pay A ₹9.00 Dividend

BIOS5286972 Bond Profile — Key Metrics

This article provides key metrics for the Option Care Health, Inc. 4.375% 31-OCT-2029 bond (BIOS5286972), including its issuer details, issue and maturity dates, outstanding amount, face value, minimum denomination, and coupon rate. It also describes Option Care Health's business as a provider of home …

OPCH|Option Care Health Inc|Price:23.665|Chg%:-0.035

This article provides a comprehensive stock analysis of Option Care Health Inc (OPCH) from TradingKey, highlighting its strong fundamentals, high growth potential, and "fairly valued" status within the Healthcare Providers & Services industry. It notes strong institutional ownership, recent "Buy" ratings from analysts with …

The Sharda Cropchem Limited (NSE:SHARDACROP) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Option Care Health (NASDAQ:OPCH) Upgraded to "Buy" at Wall Street Zen

Option Care Health (NASDAQ:OPCH) was upgraded to a "Buy" rating from "Hold" by Wall Street Zen. The company recently reported strong quarterly earnings, beating estimates with $1.44 billion in revenue and $0.45 EPS. Despite this upgrade, the broader analyst consensus remains a "Hold" with …

OPCH Q2 Deep Dive: Execution on Acute and Chronic Portfolios Drives Outperformance

OPCH Q2 Deep Dive: Execution on Acute and Chronic Portfolios Drives Outperformance Alternate site health provider Option Care Health (NASDAQ:OPCH) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 1.9% year on year to $1.44 billion. The company expects the …

Renaissance Technologies LLC Purchases 75,100 Shares of Option Care Health, Inc. $OPCH

Renaissance Technologies LLC increased its stake in Option Care Health (NASDAQ:OPCH) by 15.5%, acquiring an additional 75,100 shares, bringing its total to 558,926 shares valued at $15 million. Institutional investors now own 98.05% of the company, while insiders recently purchased 73,264 shares totaling about …

Bank of America Securities Keeps Their Hold Rating on Option Care Health (OPCH)

Bank of America Securities analyst Joanna Gajuk reiterated a Hold rating on Option Care Health (OPCH) with a price target of $25.00, following the company's recent earnings report. Option Care Health reported quarterly revenue of $1.44 billion and a net profit of $53.91 million …

Option Care Health earnings up next as census recovery takes center stage

Option Care Health (OPCH) is set to report its second-quarter results, with investor attention focused on patient census recovery amidst biosimilar drug headwinds and competitive pressures. Analysts expect improved sequential earnings and revenue, but year-over-year revenue growth is anticipated to be flat, leading to …

Option Care Health Inc Earnings Call Shows Cautious Momentum

Option Care Health Inc. (OPCH) reported its Q2 2026 earnings, showcasing cautious momentum with solid sequential revenue and EBITDA gains, strong cash generation, and an active share repurchase program. Despite these positives, the company faces headwinds in its chronic inflammatory disease portfolio, which is …

Option Care Health's Q2 Adjusted Earnings, Revenue Rise

Option Care Health (OPCH) reported an increase in its Q2 adjusted earnings, reaching $0.45 per diluted share. Revenue also rose during the quarter. The full details of the article require a premium subscription.

Sharda Cropchem Ltd (BOM:538666) (Q1 2027) Earnings Call Highlights: Revenue Climbs 9% as ...

Option Care Health (OPCH) Stock Drops As Cash Strength Meets Chronic Uncertainty

Barrington Maintains Option Care Health(OPCH.US) With Buy Rating, Raises Target Price to $33

Barrington has reiterated its "Buy" rating for Option Care Health (OPCH.US) and increased its price target to $33. This indicates a positive outlook from the analyst firm regarding the company's future performance and stock value.

Option Care Health (OPCH) Could Be 27% Undervalued After Q2 Results And Guidance

Option Care Health (OPCH) recently released strong Q2 2026 results and updated guidance, leading to a 7.06% 30-day stock price return. Despite a year-to-date decline of 30.37%, the company is considered undervalued by some analyses, with a fair value estimate of $28.58 against a …

Deutsche Bank Downgrades Option Care Health to Hold From Buy, Adjusts PT to $24 From $26

Deutsche Bank has downgraded Option Care Health (OPCH) from a "Buy" rating to "Hold" and reduced its price target from $26 to $24. This action indicates a revised outlook on the stock's performance. Previously, Stephens also downgraded Option Care to "Equal Weight" from "Overweight" …

Deutsche Bank cuts Option Care Health stock rating on growth concerns

Deutsche Bank downgraded Option Care Health (NASDAQ:OPCH) from Buy to Hold, lowering its price target to $24.00 from $26.00 due to concerns about the company's long-term growth prospects. Despite an EBITDA beat, the firm noted challenges in maintaining acute growth significantly above market and …

Option Care: Q2 Earnings Snapshot

This article provides a brief earnings snapshot for Option Care's Q2 performance. As a content cleaning and metadata extraction exercise, the article itself contains no financial details or specific figures beyond its title. It's an example of an article placeholder or a very short, …

GUIDANCE: (OPCH) Option Care Health Expects Full Year 2026 Revenue Range $5.68B - $5.78B, Vs. FactSet Est of $5.71B

Option Care Health (OPCH) announced its financial guidance for the full year 2026, expecting revenue to be in the range of $5.68 billion to $5.78 billion. This guidance compares to FactSet's estimated revenue of $5.71 billion for the same period.

Ensign Group, Humana, Vitas Healthcare, Option Care Health report second-quarter earnings

The Ensign Group, Humana, Vitas Healthcare, and Option Care Health recently reported their second-quarter earnings. Ensign Group saw strong demand and anticipates a busy acquisition period, planning to expand into new states and having acquired 71 assets since 2025. Humana reaffirmed its commitment to …

Option Care Health Q2 Earnings Rise; Provides Q3 View; Reaffirms FY26 Revenue Outlook; Stock Up

(RTTNews) - Option Care Health, Inc. (OPCH) announced financial results for the second quarter ended on June 30, 2026, reflecting improved earnings. In addition, the company provided third-quarter guidance and reaffirmed its outlook for full-year 2026. Following the news, OPCH is up over 6%. …

Option Care Health (NASDAQ:OPCH) Shares Gap Up on Earnings Beat

Option Care Health Releases Q2 2026 Financial Results

Option Care Health (OPCH) exceeded Wall Street expectations for the first half of 2026, reporting adjusted earnings per share of $0.45 and revenue of $1.44 billion. The company, a leading home infusion therapy provider, projects full-year 2026 adjusted EPS between $1.85 and $1.92, with …

Option Care (OPCH) Beats Q2 Earnings and Revenue Estimates

Option Care (OPCH) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Option Care Health (NASDAQ:OPCH) Issues FY 2026 Earnings Guidance

Option Care Health (NASDAQ:OPCH) announced its FY 2026 earnings guidance, projecting EPS of $1.85–$1.92, which is higher than the consensus estimate of $1.80. The company also expects revenue between $5.7 billion and $5.8 billion, aligning with analyst forecasts. This announcement follows a strong quarterly …